Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-10-27-Speech-4-254-500"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-10-27"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20111027.17.4-254-500"2
lpv:hasSubsequent	lp_eu:2011-10-27-Speech-4-255-0002
lpv:speaker	lp:Marielle de Sarnez2
lpv:spokenAs	member; INTA (2009-07-16--2012-01-18)3 substitute; Delegation to the Euro-Latin American Parliamentary Assembly (2009-09-16--2014-06-30)3 vice-chair; ALDE (2009-07-14--2014-06-30)3 substitute; AFET (2009-07-16--2012-01-18)3 unknown; Mouvement Démocrate (2009-07-14--2014-06-30)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation for relations with the countries of the Andean Community (2009-09-16--2014-06-30)3
lpv:translated text	"‘Ultra-resistant’ bacteria claim the lives of approximately 25 000 people in the European Union each year. To combat increasing resistance to these bacteria, stricter controls on the use of antimicrobial agents, such as antibiotics, are necessary. Half of Europeans incorrectly think that antibiotics can treat viral infections and colds. The European Union and the Member States must therefore improve the quality of information and organise prevention campaigns. Similarly, the risk of resistance to antibiotics being transmitted from animals to humans must be reduced by separating, to the extent possible, the active ingredients used in veterinary medicine and those used in human medicine. Finally, the use in agriculture of ‘last resource’ antibiotics targeting problematic human pathogens should be permitted ‘only within the framework of an authorisation, accompanied by resistance surveillance, preferably on a case-by-case basis’."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph